MARKET WIRE NEWS

Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)

Source: SeekingAlpha

2026-06-25 22:45:53 ET

I cover both Merck ( MRK ) and Merck KGaA ( MKGAF ) (which I hereafter will call "Merck", because this article is about the latter), but the latter is more of a focus for me given what's been going on in the company. Part of my thesis has finally been vindicated (it's been a long and tricky investment thus far), and we're finally seeing some gains on this investment. The last 3 articles on the company here on Seeking Alpha are from me, and the company jumped nearly 5% on intraday trading as I am writing this piece. You can find my last article here. ...

Read the full article on Seeking Alpha

For further details see:

Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)
Bio-Techne Corp

NASDAQ: TECH

TECH Trading

-0.43% G/L:

$71.64 Last:

1,645,010 Volume:

$72 Open:

mwn-press-release-boost Ad 900
?>

TECH Latest News

$10,163,205,848
154,419,399
N/A
268
N/A
Biotechnology & Life Sciences
Healthcare
US
Minneapolis

Check Your Online Brokerage For TECH

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App